In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations

Pharmaceutical Technology

Editors' Picks of Pharmaceutical Science & Technology Innovations


uprox1 proximity sensors (Turck)
The pharmaceutical manufacturing line transforms research into reality, but it takes the right kind of equipment and technology to turn ingredients into dosage forms. With recent advances in material-handling equipment and automation devices, laboratory and manufacturing technicians can be more confident about their processes and end products. This month's highlighted products all play a role in making manufacturing more efficient.

Encapsulator handles highly potent products


Isolated IN-CAP encapsulator (Schaefer Technologies)
The "Isolated IN-CAP" capsule-filling system from Schaefer Technologies (Indianapolis, IN) and Dott. Bonapace (Milan) is designed for containing highly potent products. The IN-CAP encapsulator is enclosed in an isolator specially designed by Schaefer. Operators access the unit through ergonomically designed gloveports. Nathan Lawrence, project engineer at Schaefer, says the machine's gloveports have electronically monitored safety covers. If an operator opens a safety cover when the encapsulator is running, the unit will stop.

The unit's dynamic airlock is protected by a high-efficiency particulate air (HEPA) filter and maintains operator exposure at the nanogram level.

The encapsulator incorporates a closed air system and does not require external venting. Screens protect the HEPA filters on the exhaust and inlet sides of the unit during operation. The HEPA filters keep the fan and plenums out of the contaminated area, Lawrence adds.

Factor-1 sensors withstand washdown environments

The Factor-1 "uprox+" proximity sensors from Turck (Minneapolis, MN) sense all metals at the same range. The devices are available with sensing ranges as high as 30 mm and barrel sizes from 12 to 30 mm.

The units are appropriate for washdown processes in the pharmaceutical industry. The sensors' cap is made of a liquid-crystal polymer that resists harsh chemicals. Double sealing protects the sensors against moisture ingress. The units' stainless steel construction resists continuous pressures of 145 psi. In addition, the sensors withstand temperatures from-40 to 100 °C.

Compact conveyor saves energy


C2100-64 conveyor (PIAB)
The "C2100-64" conveyor from PIAB (Täby, Sweden) is designed for areas with low headroom. The machine's overall height is about 11.5 in. Even when space above a tablet press is limited, users can slide the conveyor above it, according to Vincent Thomas, PIAB's industry manager for the pharmaceutical and chemical industries.

The conveyor features "COAX" multistage ejector technology, which allows the unit to consume less air and energy than pneumatically driven vacuum conveyors. The conveyor operates with feed pressures of 58–87 psi and working temperatures of 0–140 °F. Thomas says the conveyor is designed for low flow rates (around 1200 lb/h).

The device is assembled with triclover-style band clamps. It can be quickly disassembled, cleaned, and reassembled in less than 20 min without tools, Thomas says. A 0.5-μm filter prevents powder from entering the vacuum pump.

New Product Announcements may be sent to New Products Editor, Pharmaceutical Technology, 485 Route One South, Building F, First Floor, Iselin, NJ 08830, fax 732.596.0005,

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here